 |
|
Gene therapy completely suppresses ovarian cancer growth in animal model
June 05, 2006BALTIMORE— University of Pittsburgh School of Medicine researchers have used gene therapy to either completely abolish or significantly inhibit tumor progression in a mouse model of ovarian cancer. The researchers believe these findings, which are being presented at the American Society of Gene Therapy annual meeting in Baltimore, May 31 to June 4, may significantly improve the prognosis for ovarian cancer patients.
Ovarian cancer is diagnosed in more than 25,000 women in the United States each year, and about 16,000 American women die from the disease annually. Despite aggressive surgery and chemotherapy approaches, the prognosis for ovarian cancer is poor, and most women have a life expectancy of only three to four years after their diagnoses.
In this study, the Pitt investigators inoculated mice with an ovarian cancer cell line. They treated some of the mice immediately with a genetically engineered vaccinia virus containing a gene coding cytosine deaminase, a suicide gene, and delayed treatment of other mice for 30 or 60 days. Control mice were inoculated with ovarian cancer cells but were not given the gene therapy.
The researchers found complete inhibition of tumor growth in the mice that were treated immediately with gene therapy and significant tumor inhibition in the 30- and 60-day delayed treatment mice. In contrast, all non-gene-therapy treated mice either died or were euthanized due to overwhelming buildup of fluid in the peritoneal cavity by 94 days following tumor inoculation.
According to corresponding author David L. Bartlett, M.D., professor of surgery and chief of the division of surgical oncology at the University of Pittsburgh School of Medicine, gene therapy offers an attractive new approach for treating ovarian cancer. "Current treatments for ovarian cancer are fairly harsh. Given their tumor selectivity and cancer killing potential, vaccinia vectors expressing recombinant gene products represents a potent, non-toxic alternative for treating this deadly disease," he said.
University of Pittsburgh Medical Center
The researchers found complete inhibition of tumor growth in the mice that were treated immediately with gene therapy and significant tumor inhibition in the 30- and 60-day delayed treatment mice. In contrast, all non-gene-therapy treated mice either died or were euthanized due to overwhelming buildup of fluid in the peritoneal cavity by 94 days following tumor inoculation.
According to corresponding author David L. Bartlett, M.D., professor of surgery and chief of the division of surgical oncology at the University of Pittsburgh School of Medicine, gene therapy offers an attractive new approach for treating ovarian cancer. "Current treatments for ovarian cancer are fairly harsh. Given their tumor selectivity and cancer killing potential, vaccinia vectors expressing recombinant gene products represents a potent, non-toxic alternative for treating this deadly disease," he said.
University of Pittsburgh Medical Center
Ovarian Cancer News and Current Ovarian Cancer Events RSSNew method to overcome multiple drug resistant diseases developed by Stanford researchers
Many drugs once considered Charles Atlases of the pharmaceutical realm have been reduced to the therapeutic equivalent of 97-pound weaklings as the diseases they once dispatched with ease have developed resistance to them.
How chemo kills tumours: research to reduce side effects
Dr Stephen Taylor and Karen Gascoigne at the University's Faculty of Life Sciences have taken a new systematic approach to studying anti-mitotic drugs, which are used extensively for breast or ovarian cancer in the UK.
American Cancer Society study finds high use of complementary methods among cancer survivors
A new study from researchers at the American Cancer Society finds many cancer patients use complementary and alternative methods, most often prayer, relaxation, supplements, meditation, and massage.
Study finds that significant proportion of men told wife's cancer was incurable late or not at all
A study conducted in Sweden found that more than 40 percent of widowers in that country whose wives died from cancer four or five years earlier reported they were either never told that their spouse's cancer was incurable, or they heard this information during the last week of her life.
Symptom screening plus a simple blood test improves early detection of ovarian cancer
Women's reports of persistent, recent-onset symptoms linked to ovarian cancer - abdominal or pelvic pain, difficulty eating or feeling full quickly and abdominal bloating - when combined with the CA125 blood test may improve the early detection of ovarian cancer by 20 percent.
PET/CT scan could be valuable noninvasive tool for determining stages of ovarian cancer
Combined positron emission tomography (PET) and computed tomography (CT) scanning of patients in the early stages of ovarian cancer can enable physicians to determine whether the cancer has spread to nearby lymph nodes without having to perform surgery.
Glypican-3 gene function in regulating body size helps inform novel cancer treatments
In a leading study that has implications for the development of novel therapies for a number of breast, lung and ovarian cancers that have lost the expression of a gene called glypican-3 (GPC3), Sunnybrook researchers have discovered how the loss of the GPC3 gene induces overgrowth through certain growth factors such as Sonic Hedgehog which stimulate cancer growth.
Researchers identify new cell targets for preventing growth of breast and other tumors
Researchers at the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have discovered new targets for cancer treatment aimed at blocking a key step in tumor progression.
Researchers identify new cell targets for preventing growth of breast and other tumors
Researchers at the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have discovered new targets for cancer treatment aimed at blocking a key step in tumor progression.
Ovarian cancer stem cells identified, characterized
Researchers at Yale School of Medicine have identified, characterized and cloned ovarian cancer stem cells and have shown that these stem cells may be the source of ovarian cancer's recurrence and its resistance to chemotherapy.
More Ovarian Cancer News Articles
 | It's My Ovaries, Stupid! by Elizabeth Lee Vliet This landmark work in women's health identifies and offers solutions to the hormonal dysfunctions afflicting millions of young women, teens, and even children, that rob women of future fertility and contribute to devastating problems -- from early onset puberty and obesity to depression and increased cancer risk. Women's health is more than breast cancer, pregnancy, and menopause. In this... |
 | A Guide to Survivorship for Women with Ovarian Cancer (A Johns Hopkins Press Health Book) by F. J. Montz, Robert E. Bristow This comprehensive guide to ovarian cancer offers a wealth of information to ease the physical, emotional, and psychic suffering of women with the disease. The authors -- two Johns Hopkins gynecologic oncologists and a gynecologic-oncology clinical nurse -- put particular emphasis on the concept of "survivorship," or living life well in the face of daunting uncertainties. They stress the... |
 | Ovarian Cancer Journeys: Survivors Share Their Stories To Help Others by Ayala Miron "All of the research has reinforced that ovarian cancer is not a silent disease as was once thought and as is shown quite eloquently in this collection of stories.... The value of this collection of stories is that it helps raise awareness about symptoms, need for patient persistence, and the importance of being treated by a gynecologic oncologist." Barbara A. Goff, MD Professor and... |
 | Ovarian Cancer (Patient-Centered Guides) by Kristine Conner, Lauren Langford This unique guide for ovarian cancer gives women crucial medical information to improve the chance for lengthy remission and cure, as well as emotional support for the journey. Although many ovarian cancers are discovered after they have spread, having information about surgery and best practices can be life-saving. For example, choosing a surgeon from the new specialty of gynecologic oncology... |
 | Gilda's Disease: Sharing Personal Experiences and a Medical Perspective on Ovarian Cancer by Steven Piver The first book on ovarian cancer for the general reader, this is a comprehensive, compassionate look at a disease millions of people first became aware of with the tragic death of comedienne Gilda Radner in 1989. Dr. Piver, a leading cancer surgeon, discusses the causes of ovarian cancer, preventative measures, classic signs and symptoms, diagnostic tests and genetic screening, the different... |
 | 100 Questions & Answers About Ovarian Cancer, Second Edition by Don S. Dizon Whether you're a newly diagnosed ovarian cancer patient, a survivor, or a friend or relative of either, this completely updated second edition gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and much more. Written by a gynecologic oncologist and a gynecologic surgeon, with actual patient commentary, ... |
 | Advances in Peritoneal Surface Oncology (Recent Results in Cancer Research) Malignant peritoneal disease in its various forms is a devastating condition for patients who suffer from it and it poses a significant challenge for the clinicians taking care of them. Research efforts in this field have traditionally been scarce under the assumption of a uniformly fatal and hopeless outcome. In the last few decades a renewed interest in peritoneal carcinomatosis and primary... |
 | An Energetic Approach to Oncology (Chinese Medical Qigong Therapy, Volume 5) The information contained within the Chinese Medical Qigong Therapy: A Comprehensive Clinical Text has currently been tripled, and formatted into five exciting new textbooks. The five new Medical Qigong textbooks are composed of both modern and ancient knowledge, graphics and expanded techniques guaranteed to fascinate and intrigue the reader. Never before in the history of Chinese Medicine has a... |
 | No Time to Die:: Living with Ovarian Cancer by Liz Tilberis In 1993 Liz Tilberis seemed to have it all. She was a working mother with a family who adored her. As editor-in-chief of Harper's Bazzar, she lived at the center of the glamorous world of international fashion and was widely recognized as one of the most powerful people in the industry. And in 1993, Liz Tilberis was diagnosed with Stage III ovarian cancer.Suddenly she was faced with the challenge... |
| Women's Cancers: Pathways to Healing: A Patients Guide to Dealing with Ovarian and Breast Cancer by Giuseppe Del Priore, J Richard Smith The first goal of the book is to provide the patient with accurate information. The second goal is to show how a combination of “orthodox medicine” and complementary therapies, ranging from acupuncture to homeopathy, hypnotherapy, reiki, etc., allow people the best way through their diagnosis, treatment and follow up. Early chapters apply to all women diagnosed with cancer,... |
| © 2008 BrightSurf.com |